Embla Medical Statistics

Total Valuation

Embla Medical has a market cap or net worth of GBP 1.48 billion. The enterprise value is 1.82 billion.

Market Cap	1.48B
Enterprise Value	1.82B

Important Dates

The next estimated earnings date is Tuesday, July 22, 2025.

Earnings Date	Jul 22, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	426.40M
Shares Outstanding	n/a
Shares Change (YoY)	-0.29%
Shares Change (QoQ)	+4.94%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	160.82M

Valuation Ratios

The trailing PE ratio is 26.43 and the forward PE ratio is 23.55.

PE Ratio	26.43
Forward PE	23.55
PS Ratio	2.22
PB Ratio	2.38
P/TBV Ratio	n/a
P/FCF Ratio	17.90
P/OCF Ratio	15.16
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.58, with an EV/FCF ratio of 22.05.

EV / Earnings	32.57
EV / Sales	2.72
EV / EBITDA	13.58
EV / EBIT	18.90
EV / FCF	22.05

Financial Position

The company has a current ratio of 1.74, with a Debt / Equity ratio of 0.66.

Current Ratio	1.74
Quick Ratio	0.90
Debt / Equity	0.66
Debt / EBITDA	3.13
Debt / FCF	4.96
Interest Coverage	5.36

Financial Efficiency

Return on equity (ROE) is 9.46% and return on invested capital (ROIC) is 5.74%.

Return on Equity (ROE)	9.46%
Return on Assets (ROA)	4.80%
Return on Invested Capital (ROIC)	5.74%
Return on Capital Employed (ROCE)	8.94%
Revenue Per Employee	165,987
Profits Per Employee	13,966
Employee Count	4,061
Asset Turnover	0.55
Inventory Turnover	2.14

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -0.34% in the last 52 weeks. The beta is 0.58, so Embla Medical's price volatility has been lower than the market average.

Beta (5Y)	0.58
52-Week Price Change	-0.34%
50-Day Moving Average	31.86
200-Day Moving Average	37.67
Relative Strength Index (RSI)	42.87
Average Volume (20 Days)	11,988

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Embla Medical had revenue of GBP 663.95 million and earned 55.86 million in profits. Earnings per share was 0.13.

Revenue	663.95M
Gross Profit	419.53M
Operating Income	93.21M
Pretax Income	73.71M
Net Income	55.86M
EBITDA	110.68M
EBIT	93.21M
Earnings Per Share (EPS)	0.13

Full Income Statement

Balance Sheet

The company has 71.03 million in cash and 409.09 million in debt, giving a net cash position of -338.06 million.

Cash & Cash Equivalents	71.03M
Total Debt	409.09M
Net Cash	-338.06M
Net Cash Per Share	n/a
Equity (Book Value)	620.49M
Book Value Per Share	1.45
Working Capital	137.96M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 97.40 million and capital expenditures -14.89 million, giving a free cash flow of 82.51 million.

Operating Cash Flow	97.40M
Capital Expenditures	-14.89M
Free Cash Flow	82.51M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 63.19%, with operating and profit margins of 14.04% and 8.41%.

Gross Margin	63.19%
Operating Margin	14.04%
Pretax Margin	11.10%
Profit Margin	8.41%
EBITDA Margin	16.67%
EBIT Margin	14.04%
FCF Margin	12.43%

Dividends & Yields

Embla Medical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.29%
Shareholder Yield	0.29%
Earnings Yield	3.78%
FCF Yield	5.59%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Embla Medical has an Altman Z-Score of 3.09.

Altman Z-Score	3.09
Piotroski F-Score	n/a